Divergent effects of cytokines on human leukocyte antigen‐DR antigen expression of neoplastic and non‐neoplastic human thyroid cells

Apparently complex modulatory effects of alpha‐interferon (α ‐IFN), tumor necrosis factor (TNF), and epidermal growth factor (EGF) have been found in neoplastic human thyroid cells, which could possibly affect the final outcome in neoplastic disease. This was achieved by examining the influence of α‐IFN, TNF, and EGF alone and in combination, on human leukocyte antigen‐DR (DR) antigen expression and viability of neoplastic and non‐neoplastic human thyroid cells in culture. α‐IFN‐induced DR antigen expression on non‐neoplastic human thyroid cells, whereas TNF‐α or EGF alone were ineffective. The addition of the same TNF‐α concentrations (10 to 100 ng/ml) to α‐IFN enhanced the expression of DR antigens compared with the effect of α‐IFN alone. However, EGF inhibited α‐IFN‐induced DR on the same cells and at the same concentrations (10 to 500 ng/ml) at which the growth factor alone was ineffective. In contrast to the common pattern of cytokine effects on DR expression of all nonmalignant thyroid cell lines, neoplastic thyroid cell lines showed divergent responses to α‐IFN, TNF‐α, and EGF. In three malignant thyroid cell lines that were DR negative (follicular carcinoma WRO 82‐1 and NRO 87‐1 cell lines, and anaplastic carcinoma ARO 81‐1), DR antigen could be induced by α‐IFN and enhanced by TNF‐α, whereas EGF was ineffective. In a fourth cell line (an anaplastic carcinoma SW1736) α‐IFN, TNF‐α, and EGF alone were capable of inducing DR, and a combination of either TNF‐α and EGF with α‐IFN potentiated DR induction. In a fifth neoplastic cell line (papillary carcinoma, NPA) that constitutively expressed surface DR, its expression was inhibited by both α‐IFN and TNF‐α and was not affected by EGF.

[1]  I. Todd,et al.  Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies. , 1988, The Journal of clinical endocrinology and metabolism.

[2]  R. Volpe Immunoregulation in autoimmune thyroid disease. , 1987, The New England journal of medicine.

[3]  A. Fauci,et al.  The in vitro regulation of human thyrocyte HLA-DR antigen expression. , 1985, The Journal of clinical endocrinology and metabolism.

[4]  P. Scheurich,et al.  Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. , 1987, Journal of immunology.

[5]  M. Feldmann,et al.  Epidermal growth factor and transforming growth factor-alpha suppress HLA class II induction in human thyroid epithelial cells. , 1990, Immunology.

[6]  R. Ian Freshney,et al.  Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications , 2010 .

[7]  D. Taramelli,et al.  Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions. , 1986, Cancer research.

[8]  B. Seliger,et al.  Differential γ-Interferon Response of Human Colon Carcinoma Cells: Inhibition of Proliferation and Modulation of Immunogenicity as Independent Effects of γ-Interferon on Tumor Cell Growth , 1985 .

[9]  W. Fiers,et al.  Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Mckenzie,et al.  Influence of cytokines on growth and differentiated function of FRTL5 cells. , 1989, Endocrinology.

[11]  K. Ito,et al.  Epidermal growth factor receptors in plasma membranes of normal and diseased human thyroid glands. , 1989, The Journal of clinical endocrinology and metabolism.

[12]  J. Hershman,et al.  Characterization of tumor necrosis factor-alpha receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. , 1989, Endocrinology.

[13]  T. Maudelonde,et al.  The Lancet: saturday 11 November 1989 , 1989 .

[14]  M. Feldmann,et al.  ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY , 1983, The Lancet.

[15]  B. Beutler,et al.  Brief Definitive Report Cachectin/tumor Necrosis Factor Stimulates Collagenase and Prostaglandin E2 Production by Human Synovial Cells and Dermal , 2022 .

[16]  I. Lampert,et al.  HLA‐DR expression in a human colonic carcinoma cell linexs , 1985, The Journal of pathology.

[17]  S. Ferrone,et al.  Gene products of the HLA-D region in normal and malignant tissues of nonlymphoid origin. , 1986, Human immunology.

[18]  I. Todd,et al.  Influence of Tumor Necrosis Factor-α on the Modulation by Interferon-γ of HLA Class II Molecules in Human Thyroid Cells and Its Effect on Interferon-γ Binding , 1989 .

[19]  G. Khoury,et al.  Modulation of the tumorigenicity of human adenovirus-12-transformed cells by interferon , 1985, Cell.

[20]  K. Franssila,et al.  Receptors for epidermal growth factor and thyrotropin in thyroid carcinoma. , 1988, Acta endocrinologica.

[21]  H. Imura,et al.  Epidermal growth factor receptors on cultured neoplastic human thyroid cells and effects of epidermal growth factor and thyroid-stimulating hormone on their growth. , 1988, Cancer research.

[22]  K. Kasai,et al.  Presence of epidermal growth factor receptors on human thyroid membranes. , 1987, Acta endocrinologica.

[23]  M. Bennett,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURS , 1985, The Lancet.

[24]  B. Elliott,et al.  Perspectives on the role of MHC antigens in normal and malignant cell development. , 1989, Advances in cancer research.

[25]  J. Lamb,et al.  Effects of platelet-derived growth factor and epidermal growth factor on antigen-induced proliferation of human T-cell lines. , 1985, Immunology.

[26]  M. Feldmann,et al.  Interferon-gamma induces HLA-DR expression by thyroid epithelium. , 1985, Clinical and experimental immunology.

[27]  A. Ghosh,et al.  Expression of HLA‐D sub‐region products on human colorectal carcinoma , 1986, International journal of cancer.

[28]  Q. Duh,et al.  Epidermal growth factor receptors in normal and neoplastic thyroid tissue. , 1985, Surgery.

[29]  A. Rees,et al.  Synergistic effects of recombinant tumour necrosis factor and interferon-gamma on rat thyroid cell growth and Ia antigen expression. , 1988, Immunology.

[30]  B. Beutler,et al.  A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. , 1985, Science.

[31]  F. Hornicek,et al.  Effects of γ-interferon and tumor necrosis factor α on thyroid cells: induction of class II antigen and inhibition of growth stimulation , 1988, Molecular and Cellular Endocrinology.

[32]  N. Goldsmith,et al.  HLA class II antigen expression and the autoimmune thyroid response in patients with benign and malignant thyroid tumors. , 1988, Clinical immunology and immunopathology.

[33]  A. Harris Letter: Vitamin-C-induced hyperoxaluria. , 1976, Lancet.

[34]  A. Cooke,et al.  Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferon‐γ , 1987, European journal of immunology.

[35]  G. Sherbet,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCER , 1985, The Lancet.

[36]  T. Davies,et al.  REOVIRUS INDUCTION OF MHC CLASS II ANTIGEN IN RAT THYROID CELLS , 1989, Endocrinology.

[37]  A. Dayan,et al.  BIRTH CONTROL FOR PROBLEM PARENTS. , 1964, Lancet.

[38]  G. Trinchieri,et al.  Immune interferon: a pleiotropic lymphokine with multiple effects. , 1985, Immunology today.

[39]  D. Doniach,et al.  ABERRANT EXPRESSION OF HLA-DR ANTIGEN ON THYROCYTES IN GRAVES' DISEASE: RELEVANCE FOR AUTOIMMUNITY , 1983, The Lancet.

[40]  B. Glaser,et al.  Bioassay of thyroid-stimulating immunoglobulin in cryopreserved human thyroid cells: optimization and clinical evaluation. , 1988, Clinical chemistry.

[41]  J. Gamble,et al.  Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.